Show simple item record

dc.contributor.authorMangione, Carol M
dc.contributor.authorBarry, Michael J
dc.contributor.authorNicholson, Wanda K
dc.contributor.authorCabana, Michael
dc.contributor.authorCoker, Tumaini Rucker
dc.contributor.authorDavidson, Karina W
dc.contributor.authorDavis, Esa M
dc.contributor.authorDonahue, Katrina E
dc.contributor.authorJaén, Carlos Roberto
dc.contributor.authorKubik, Martha
dc.contributor.authorLi, Li
dc.contributor.authorOgedegbe, Gbenga
dc.contributor.authorPbert, Lori
dc.contributor.authorRuiz, John M
dc.contributor.authorSilverstein, Michael
dc.contributor.authorStevermer, James
dc.contributor.authorWong, John B
dc.date.accessioned2023-01-03T15:45:30Z
dc.date.available2023-01-03T15:45:30Z
dc.date.issued2022-10-11
dc.identifier.citationUS Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Coker TR, Davidson KW, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Silverstein M, Stevermer J, Wong JB. Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 Oct 11;328(14):1438-1444. doi: 10.1001/jama.2022.16936. PMID: 36219403.en_US
dc.identifier.eissn1538-3598
dc.identifier.doi10.1001/jama.2022.16936en_US
dc.identifier.pmid36219403
dc.identifier.urihttp://hdl.handle.net/20.500.14038/51516
dc.description.abstractImportance: Anxiety disorder, a common mental health condition in the US, comprises a group of related conditions characterized by excessive fear or worry that present as emotional and physical symptoms. The 2018-2019 National Survey of Children's Health found that 7.8% of children and adolescents aged 3 to 17 years had a current anxiety disorder. Anxiety disorders in childhood and adolescence are associated with an increased likelihood of a future anxiety disorder or depression. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in children and adolescents. This is a new recommendation. Population: Children and adolescents 18 years or younger who do not have a diagnosed anxiety disorder or are not showing recognized signs or symptoms of anxiety. Evidence assessment: The USPSTF concludes with moderate certainty that screening for anxiety in children and adolescents aged 8 to 18 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety in children 7 years or younger. Recommendation: The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger. (I statement).en_US
dc.language.isoenen_US
dc.relation.ispartofJAMAen_US
dc.relation.urlhttps://doi.org/10.1001/jama.2022.16936en_US
dc.titleScreening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statementen_US
dc.typeJournal Articleen_US
dc.source.journaltitleJAMA
dc.source.volume328
dc.source.issue14
dc.source.beginpage1438
dc.source.endpage1444
dc.source.countryUnited States
dc.identifier.journalJAMA
dc.contributor.departmentPopulation and Quantitative Health Sciencesen_US
dc.contributor.departmentPrevention Research Centeren_US


This item appears in the following Collection(s)

Show simple item record